BDgene Therapeutics bags funding and 47 more updates from Greater China worth over $1.5b

BDgene Therapeutics bags funding and 47 more updates from Greater China worth over $1.5b

Shanghai-headquartered gene therapy firm BDgene Therapeutics has secured 200 million yuan ($27.5 million) in a Series B financing round led by biopharma-focused domestic investor Lapam Capital.  

Edited by: Joymitra Rai